![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » AMIS, IRM Agreement Will Deliver Semiconductors for Devices
AMIS, IRM Agreement Will Deliver Semiconductors for Devices
April 19, 2005
AMI Semiconductor (AMIS), a designer and manufacturer of state-of-the-art integrated mixed-signal and structured digital products, has announced a technology design and supply partnership with Interventional Rhythm Management (IRM), the specialist cardiology company dedicated to the management of patients with cardiac arrhythmias and heart failure. Under the terms of the agreement, AMIS will provide custom, low-power mixed-signal application specific integrated circuit (ASIC) solutions that will be used in IRM's design for cardiac electrophysiology devices such as implantable defibrillators and pacemakers.
Reuters
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
21Oct